Non-small Cell Lung Cancer (NSCLC) Clinical Trials in Tokyo
3 recruitingTokyo, Japan
Showing 1–3 of 3 trials
Recruiting
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer (NSCLC)
Takeda500 enrolled1 locationNCT05100069
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC556 enrolled192 locationsNCT06074588
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478